Table 4.

Demographic and clinical details of group ‘B’ hosts.

Patient Number	Age at Admission	Sex	Bone Affected	Length of Admission	Causative Organism	IV Antibiotic Prescribed	Recurrence
25	54	M	Tibia	7	Enterobacter cloacae	Teicoplanin IV	No
26	28	M	Femur	16	Staph aureus	Meropenem IV	No
27	55	M	Femur	73	Proteus mirabilis	Vancomycin IV	No
28	37	F	Femur	16	No Growth	Vancomycin IV	No
29	20	F	Tibia	2	Staph aureus	Benzyl Penicillin IV	No
30	55	F	Tibia	7	P. aeruginosa	Vancomycin IV	Yes
31	36	M	Tibia	14	Streptococcus milleri	Oral antibiotics only	No
32	60	F	Femur	11	Coagulase Negative Staph	Oral antibiotics only	No
33	44	M	Ulna	7	Coagulase Negative Staph	Vancomycin IV	No
34	31	M	Ulna	7	No Growth	Vancomycin IV	Yes
35	16	F	Femur	2	MRSA	Vancomycin IV	No
36	77	M	Femur	20	No Growth	Tazocin IV	No
37	62	M	Tibia	5	Coagulase Negative Staph	Vancomycin IV	No
38	42	M	Tibia	5	Staph aureus	Vancomycin IV	No
39	45	F	Clavicle	3	Staph aureus	Oral antibiotics only	No
40	46	M	Femur	12	Coagulase Negative Staph	Vancomycin IV	Yes
41	59	M	Ischium	10	Staph aureus	Flucloxacillin IV	No
42	76	F	Tibia	12	Enterobacter cloacae	Vancomycin IV	No
43	17	M	Femur	6	No Growth	Data not available	No
44	41	F	Sacrum	15	No Growth	Tazocin IV	No
45	42	M	Femur	3	Coagulase Negative Staph	Data not available	No
46	25	M	Tibia	9	No Growth	Vancomycin IV	No
47	36	M	Femur	31	Staph aureus	Vancomycin IV	No
48	32	M	Femur	2	Staph aureus	Vancomycin IV	No
49	37	M	Tibia	8	Coagulase Negative Staph	Vancomycin IV	No
50	65	M	Humerus	17	Staph aureus	Flucloxacillin IV	No
	Mean = 43.7	Male = 69%		Mean = 12.3			Total recurrences = 3
	SD = 16.7	Female = 31%		SD = 14.1